Management Strategies for Mycobacterium Avium Complex Infections: Diagnosis and Treatment of a Growing Health Threat

The incidence of nontuberculous mycobacterial infections caused by Mycobacterium avium complex (NTM-MAC) have increased dramatically in recent decades, while the 5-year survival of patients with NTM-MAC infections remains similar to that of patients with lung cancer. Diagnoses are often delayed due to the nonspecific presentation of NTM-MAC and radiological findings that overlap with other pulmonary diseases. NTM-MAC treatment is also difficult with the use of multiple antibiotic regimens and frequency of refractory disease. In recent years, the availability of amikacin liposome inhalation suspension (ALIS) has provided another option for patients with NTM-MAC who do not achieve a negative sputum culture after a minimum of six consecutive months of a multidrug regimen therapy.

Share

Program Content

Activities

  • Diagnosis and Treatment of a Growing Health Threat
    Management Strategies for Mycobacterium Avium Complex Infections: Diagnosis and Treatment of a Growing Health Threat
    Video
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 22, 2022

    Expires: August 22, 2023

Faculty

cover img faculity

Doreen Addrizzo-Harris, MD

Professor of Medicine Associate Director for Education and Faculty Affairs
Program Director, Fellowship Training
Co-Director, NYU Bronchiectasis and NTM Program
Division of Pulmonary Critical Care & Sleep Medicine
NYU Grossman School of Medicine
New York, NY

cover img faculity

Charles L. Daley, MD

Professor of Medicine
Division of Mycobacterial and Respiratory Infections Department of Medicine
National Jewish Health
Denver, Colorado

Provided by

ProCE Banner
ProCE Banner

Jointly provided by the Potomac Center for Medical Education and Rockpointe.

Supporters

This activity is supported by an educational grant from Insmed.

Insmed